Your browser doesn't support javascript.
loading
PD-L1 Testing in Urothelial Carcinoma: Analysis of a Series of 1401 Cases Using Both the 22C3 and SP142 Assays.
Evans, Harriet; O'Sullivan, Brendan; Hughes, Frances; Charles, Kathryn; Robertson, Lee; Taniere, Philippe; Diaz-Cano, Salvador.
Affiliation
  • Evans H; Molecular Pathology Diagnostic Service, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
  • O'Sullivan B; Molecular Pathology Diagnostic Service, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
  • Hughes F; Molecular Pathology Diagnostic Service, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
  • Charles K; Molecular Pathology Diagnostic Service, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
  • Robertson L; Molecular Pathology Diagnostic Service, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
  • Taniere P; Molecular Pathology Diagnostic Service, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
  • Diaz-Cano S; Molecular Pathology Diagnostic Service, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
Pathol Oncol Res ; 28: 1610260, 2022.
Article in En | MEDLINE | ID: mdl-35478498

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Lung Neoplasms Type of study: Guideline Limits: Female / Humans / Male Language: En Journal: Pathol Oncol Res Journal subject: NEOPLASIAS / PATOLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Lung Neoplasms Type of study: Guideline Limits: Female / Humans / Male Language: En Journal: Pathol Oncol Res Journal subject: NEOPLASIAS / PATOLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication: